{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:47:24Z","timestamp":1792021644058,"version":"4.4.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1997,6,1]],"date-time":"1997-06-01T00:00:00Z","timestamp":865123200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[1997,6]]},"DOI":"10.1007\/s10787-997-0023-8","type":"journal-article","created":{"date-parts":[[2007,8,10]],"date-time":"2007-08-10T22:33:46Z","timestamp":1186785226000},"page":"139-152","source":"Crossref","is-referenced-by-count":19,"title":["Etodolac in the management of pain: A clinical review of a multipurpose analgesic"],"prefix":"10.1007","volume":"5","author":[{"given":"N.","family":"Bellamy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"l","key":"23_CR1","first-page":"l","volume":"7","author":"LG Humber","year":"1987","unstructured":"Humber LG. Etodolac: The chemistry, pharmacology, metabolic dispositon, and clincial profile of a novel anti-inflammatory pyranocarboxylic acid. Med Res Rev. 1987;7(l):l-28.","journal-title":"Med Res Rev."},{"issue":"Suppl l","key":"23_CR2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF02214109","volume":"8","author":"N Zvaifler","year":"1989","unstructured":"Zvaifler N. A review of the antiarthritic efficacy and safety of etodolac. Clin Rheumatol. 1989;8(Suppl l):43\u201353.","journal-title":"Clin Rheumatol."},{"issue":"2","key":"23_CR3","doi-asserted-by":"crossref","first-page":"274","DOI":"10.2165\/00003495-199142020-00008","volume":"42","author":"JA Balfour","year":"1991","unstructured":"Balfour JA, Buckley MM. Etodolac: A reappraisal of its pharmacology and therapeutic use in rheumatic diseases and pain states. Drugs. 1991;42(2):274\u201399.","journal-title":"Drugs."},{"key":"23_CR4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-94-009-0713-3_4","volume-title":"Azapropazone: 20 Years of Clinical Use","author":"KD Rainsford","year":"1989","unstructured":"Rainsford KD. The mode of action of azapropazone in relation to its therapeutic actions in rheumatic conditions and its major side effects. In: Rainsford KD, ed. Azapropazone: 20 Years of Clinical Use. Kluwer Academic Publishers, Lancaster. 1989;31\u201351."},{"key":"23_CR5","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0006-2952(84)90228-4","volume":"33","author":"HB Kaplan","year":"1984","unstructured":"Kaplan HB, Edelson HS, Korchak HM et al. Effect of non-steroidal anti-inflammatory agents on humana neutrophil function in vitro and in vivo. Biochem Pharmacol. 1984;33:371\u20138.","journal-title":"Biochem Pharmacol."},{"key":"23_CR6","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/BF02668029","volume":"3","author":"KB Glaser","year":"1995","unstructured":"Glaser KB. Cyclooxygenase selectivity and NSAIDs: Cyclooxygenase-2 selectivity of etodolac (Iodine). Inflammopharmacology. 1995;3:335\u201345.","journal-title":"Inflammopharmacology."},{"issue":"4","key":"23_CR7","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/BF00918212","volume":"8","author":"P Sirois","year":"1984","unstructured":"Sirois P, Saura C, Salari H et al. Comparative effects of etodolac, indomethacin, and benoxaprofen on icosanoid biosynthesis. Inflammation. 1984;8(4):353\u201364.","journal-title":"Inflammation."},{"issue":"4","key":"23_CR8","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2165\/00003088-199426040-00003","volume":"26","author":"DR Brocks","year":"1994","unstructured":"Brocks DR, Jamali F. Etodolac clinical pharmacokinetics. Clin Pharmacokinet. 1994;26(4):259\u201374.","journal-title":"Clin Pharmacokinet."},{"issue":"l","key":"23_CR9","first-page":"15","volume":"14","author":"LZ Benet","year":"1994","unstructured":"Benet LZ. Pharmacokinetic profile of etodolac in special populations. Eur J Rheumatol Inflam. 1994;14(l):15\u20138.","journal-title":"Eur J Rheumatol Inflam."},{"issue":"1","key":"23_CR10","first-page":"19","volume":"14","author":"PA Bacon","year":"1994","unstructured":"Bacon PA. Safety profile of etodolac in the elderly population. Eur J Rheumatol Inflam. 1994; 14(1): 19- 22.","journal-title":"Eur J Rheumatol Inflam."},{"key":"23_CR11","first-page":"56","volume":"10","author":"M Schattenkirchner","year":"1990","unstructured":"Schattenkirchner M. An updated safety profile of etodolac in several thousand patients. Eur J Rheumatol Inflamm. 1990;10:56\u201365.","journal-title":"Eur J Rheumatol Inflamm."},{"key":"23_CR12","unstructured":"Compendium of Pharmaceuticals and Specialties. Toronto, Canadian Pharmaceutical Association. 1996; 1538\u20139."},{"issue":"5A","key":"23_CR13","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/0002-9343(83)90229-2","volume":"75","author":"SA Cooper","year":"1983","unstructured":"Cooper SA. Models for clinical assessment of oral analgesics. Am J Med. 1983;75(5A):24\u20139.","journal-title":"Am J Med."},{"issue":"6","key":"23_CR14","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/0030-4220(86)90255-0","volume":"66","author":"R Scott","year":"1986","unstructured":"Scott R, Ellis III E, Upton LG. Double-blind evaluation of etodolac (200 mg, 400 mg) compared with zomepirac (100 mg) and placebo on third molar extraction pain. Oral Surg. 1986;66(6):638\u201342.","journal-title":"Oral Surg."},{"key":"23_CR15","unstructured":"Nelson SL, Bergman SA. Relief of dental surgery pain: a controlled 12-hour comparison of etodolac, aspirin, and placebo. Anesth Prog. 1985:151\u20136."},{"issue":"6","key":"23_CR16","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0030-4220(83)90070-1","volume":"56","author":"CE Hutton","year":"1983","unstructured":"Hutton CE. The effectiveness of 100 and 200 mg etodolac (Ultradol), aspirin, and placebo in patients with pain following oral surgery. Oral Surg. 1983;56(6):575\u201380.","journal-title":"Oral Surg."},{"key":"23_CR17","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0278-2391(84)80007-5","volume":"42","author":"GW Gaston","year":"1984","unstructured":"Gaston GW, Mallow RD, Frank JE. The efficacy of etodolac for patients with pain following oral surgery. J Oral Maxillofac Surg. 1984;42:362\u201366.","journal-title":"J Oral Maxillofac Surg."},{"key":"23_CR18","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/0278-2391(86)90150-3","volume":"44","author":"JA Giglio","year":"1986","unstructured":"Giglio JA, Campbell RL. Comparison of etodolac, zomepirac, and placebo for relief of pain after oral surgery. J Oral Maxillofac Surg. 1986;44:765\u201370.","journal-title":"J Oral Maxillofac Surg."},{"issue":"5","key":"23_CR19","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/j.1875-9114.1986.tb03477.x","volume":"6","author":"GW Gaston","year":"1986","unstructured":"Gaston GW, Mallow RD, Frank JE. Comparison of etodolac, aspirin and placebo for pain after oral surgery. Pharmacotherapy. 1986;6(5):199\u2013204.","journal-title":"Pharmacotherapy."},{"issue":"l","key":"23_CR20","first-page":"33","volume":"36","author":"L Fliedner","year":"1984","unstructured":"Fliedner L, Levsky M, Kechejian H. Analgesia with etodolac in oral postsurgical pain. Curr Ther Res. 1984;36(l):33\u201345.","journal-title":"Curr Ther Res."},{"key":"23_CR21","doi-asserted-by":"crossref","unstructured":"Pena M. Etodolac: analgesic effects in musculoskeletal and postoperative pain. Rheumatol Int. 1990;10(Suppl):9\u201316.","DOI":"10.1007\/BF02274750"},{"issue":"10","key":"23_CR22","first-page":"35","volume":"10","author":"M. Mizraji","year":"1990","unstructured":"Mizraji M. Clinical response to etodolac in the management of pain. Eur J Rheumatol Inflamm. 1990;10(10):35\u201343.","journal-title":"Eur J Rheumatol Inflamm."},{"issue":"5","key":"23_CR23","first-page":"236","volume":"20","author":"L Versichelen","year":"1982","unstructured":"Versichelen L, Bilsback P, Roily G et al. Etodolac in postsurgical pain: a double-blind dose-ranging efficacy study with aspirin and placebo. Int J Clin Pharmacol Ther Toxicol. 1982;20(5):236\u20139.","journal-title":"Int J Clin Pharmacol Ther Toxicol."},{"key":"23_CR24","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/978-3-642-68690-0_34","volume":"2","author":"P Bilsback","year":"1982","unstructured":"Bilsback P, Roily G, Versichelen L et al. Etodolac in postsurgical pain: Double-blind, dose-ranging efficacy study with aspirin and placebo. Cardiol Meas Anaesth. 1982;2:257\u201360.","journal-title":"Cardiol Meas Anaesth."},{"key":"23_CR25","first-page":"250","volume":"54","author":"G Roily","year":"1982","unstructured":"Roily G, Bilsback P, Versichelen L et al. Etodolac in postoperative pain: a double-blind study with aspirin and placebo. Br J Anaesth.1982;54:250-l.","journal-title":"Br J Anaesth."},{"issue":"l","key":"23_CR26","first-page":"100","volume":"33","author":"E Friedrich","year":"1983","unstructured":"Friedrich E. A comparison of etodolac (Ultradol) with aspirin and placebo in patients with episiotomy pain. CurrTherap Res. 1983;33(l):100\u20137.","journal-title":"CurrTherap Res."},{"issue":"4","key":"23_CR27","first-page":"507","volume":"14","author":"M D\u2019Hooghe","year":"1992","unstructured":"D\u2019Hooghe M. Double-blind, parallel-group evaluation of etodolac and naproxen in patients with acute sports injuries. Clin Ther. 1992;14(4):507\u201316.","journal-title":"Clin Ther."},{"issue":"7a","key":"23_CR28","first-page":"207","volume":"42","author":"CJ Menkes","year":"1990","unstructured":"Menkes CJ. Scapulo-humeral periarthritis: efficacy, safety and therapeutic benefit of etodolac (600 mg\/ daily) versus piroxicam (40\/20 mg\/daily). Rhumatologie. 1990;42(7a):207\u201312.","journal-title":"Rhumatologie."},{"issue":"7a","key":"23_CR29","first-page":"213","volume":"42","author":"D Bontoux","year":"1990","unstructured":"Bontoux D. Lumbo-radiculalgia: efficacy, safety and therapeutic benefit of etodolac (600 mg\/daily) versus diclofenac (150 mg\/daily) and placebo. Rheumatologie. 1990;42(7a):213\u201318.","journal-title":"Rheumatologie."},{"issue":"5","key":"23_CR30","first-page":"940","volume":"46","author":"L Davoli","year":"1989","unstructured":"Davoli L, Ciotti G, Biondi M, Passeri M. Piroxicam-beta-cyclodextrin in the treatment of low-back pain. CurrTher Res. 1989;46(5):940\u20137.","journal-title":"CurrTher Res."},{"key":"23_CR31","first-page":"451","volume":"101","author":"Souza A Zecchi de","year":"1991","unstructured":"Zecchi de Souza A Tacla M, Hegg R et al Etodolac in Primary dsysmenorrhoea. J Bras Ginecol 1991;101:451\u20139.","journal-title":"J Bras Ginecol"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-997-0023-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10787-997-0023-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-997-0023-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T20:23:03Z","timestamp":1559247783000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10787-997-0023-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,6]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1997,6]]}},"alternative-id":["23"],"URL":"https:\/\/doi.org\/10.1007\/s10787-997-0023-8","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,6]]}}}